IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Detail
IPO Information
Financial
Financial Report
Peer Comparison
Performance
Performance Report
Windlas Biotech IPO listing price is ₹ 406.70, issue price is [●], and currently trading at ₹ 912.35 as on May 30, 2025. Windlas Biotech IPO performance is show below with latest CAGR.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Windlas Biotech IPO is a Book Building listing on BSE,NSE exchange. The company is based in Dehradun and caters to Pharmaceutical sector. Dam Capital Advisors (Formerly Idfc Securities ) , Iifl Securities , SBI Capital Markets are the merchant bankers of Windlas Biotech IPO. It is a MainBoard IPO which filed its Draft Red Herring Prospectus (DRHP) on [●].
Windlas Biotech IPO offer price is ₹ 460.00 and got listed at ₹ 406.70. Read Windlas Biotech IPO details mentioned above.The IPO of Windlas Biotech Limited was listed on 16th August 2021. As of today, Windlas Biotech IPO is trading at ₹ 912.35, compared to the previous day’s close of ₹ 939.65. Read the report above for detailed IPO performance.
The issue price of Windlas Biotech IPO was [●] per equity share.
Windlas Biotech IPO was listed at ₹406.70 on the stock exchange on 16th August 2021. The listing price is the price at which the shares started trading on the stock exchange after the IPO was completed.
As of May 30, 2025, the current market price of Windlas Biotech IPO is ₹ 912.35.
The 52-week high for Windlas Biotech IPO is ₹ 1198.25, while the 52-week low is ₹ 555.05. These figures reflect the stock’s highest and lowest trading prices in the past one year from the current date.
The Windlas Biotech IPO listed at ₹ 406.70 against the issue price of [●] per equity share, showing a listing day gain/loss of -53.3 (-11.59%) , calculated by comparing the listing price to the issue price on the first day of trading.
The Windlas Biotech IPO stock moved from its listing price of ₹ 406.70 to the current price of ₹912.35 per equity share, reflecting a change of 124.33% per share, calculated by subtracting the listing price from the current market price (CMP) as of today.
Based on Windlas Biotech IPO issue date of May 30, 2025 and CMP of ₹912.35, the estimated CAGR is approximately 19.79%.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
*Stock splits/Reverse Stock Split are adjusted in Issue price while calculating CAGR and current performance.
Face
Value :
₹ 5
Issue
Price :
[●]
Listing Price :
₹ 406.70
Previous Day Closing
₹ 939.65
Windlas Biotech IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Windlas Biotech Financial Review Page
Merchant Banker(s) of Windlas Biotech IPO: Dam Capital Advisors Limited (Formerly Idfc Securities Limited) , Iifl Securities Limited , SBI Capital Markets Limited
Windlas Biotech IPO subscription was 22.44 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Windlas Biotech IPO listed at a listing price of 406.70 against the offer price of 460.00.
The current market price of Windlas Biotech is 912.35.
Why Us?
